These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 30031954)

  • 1. Progesterone Receptor Is Responsible for Benign Biology of Skull Base Meningioma.
    Kuroi Y; Matsumoto K; Shibuya M; Kasuya H
    World Neurosurg; 2018 Oct; 118():e918-e924. PubMed ID: 30031954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WHO grade, proliferation index, and progesterone receptor expression are different according to the location of meningioma.
    Maiuri F; Mariniello G; Guadagno E; Barbato M; Corvino S; Del Basso De Caro M
    Acta Neurochir (Wien); 2019 Dec; 161(12):2553-2561. PubMed ID: 31637512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgically resected skull base meningiomas demonstrate a divergent postoperative recurrence pattern compared with non-skull base meningiomas.
    Mansouri A; Klironomos G; Taslimi S; Kilian A; Gentili F; Khan OH; Aldape K; Zadeh G
    J Neurosurg; 2016 Aug; 125(2):431-40. PubMed ID: 26722844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature.
    Wolfsberger S; Doostkam S; Boecher-Schwarz HG; Roessler K; van Trotsenburg M; Hainfellner JA; Knosp E
    Neurosurg Rev; 2004 Oct; 27(4):238-45. PubMed ID: 15168138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Tumor Progression Patterns in Skull Base Versus Non-Skull Base Meningiomas: A Critical Analysis from a Long-Term Follow-Up Study and Review of Literature.
    Savardekar AR; Patra DP; Bir S; Thakur JD; Mohammed N; Bollam P; Georgescu MM; Nanda A
    World Neurosurg; 2018 Apr; 112():e74-e83. PubMed ID: 29258946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of clinicopathological features and surgical outcomes between pediatric skull base and non-skull base meningiomas.
    Li Z; Li H; Jiao Y; Ma J; Wang S; Zhao J; Cao Y
    Childs Nerv Syst; 2017 Apr; 33(4):595-600. PubMed ID: 27796552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inverse correlation of cell proliferation and expression of progesterone receptors in tumor spheroids and monolayer cultures of human meningiomas.
    Tonn JC; Ott MM; Bouterfa H; Kerkau S; Kapp M; Müller-Hermelink HK; Roosen K
    Neurosurgery; 1997 Nov; 41(5):1152-9. PubMed ID: 9361071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of World Health Organization tumor grades at recurrence in patients with non-skull base and skull base meningiomas.
    McGovern SL; Aldape KD; Munsell MF; Mahajan A; DeMonte F; Woo SY
    J Neurosurg; 2010 May; 112(5):925-33. PubMed ID: 19799498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery of Small Anterior Skull Base Meningiomas by Endoscopic 5-Aminolevulinic Acid Fluorescence Guidance: First Clinical Experience.
    Cornelius JF; Kamp MA; Tortora A; Knipps J; Krause-Molle Z; Beez T; Petridis AK; Sabel M; Schipper J; Steiger HJ
    World Neurosurg; 2019 Feb; 122():e890-e895. PubMed ID: 30419399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and immunohistochemical expression levels of androgen, estrogen, progesterone and Ki-67 receptors in relationship with gross-total resected meningiomas relapse.
    Tao Y; Liang G; Li Z; Wang Y; Wu A; Wang H; Lu Y; Liu Z; Hu G
    Br J Neurosurg; 2012 Oct; 26(5):700-4. PubMed ID: 22616825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant potential of skull base versus non-skull base meningiomas: clinical series of 1,663 cases.
    Cornelius JF; Slotty PJ; Steiger HJ; Hänggi D; Polivka M; George B
    Acta Neurochir (Wien); 2013 Mar; 155(3):407-13. PubMed ID: 23318687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence.
    Yesilöz Ü; Kirches E; Hartmann C; Scholz J; Kropf S; Sahm F; Nakamura M; Mawrin C
    Neuro Oncol; 2017 Aug; 19(8):1088-1096. PubMed ID: 28482067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meningiomas Display a Specific Immunoexpression Pattern in a Rostrocaudal Gradient: An Analysis of 366 Patients.
    Ülgen E; Bektaşoğlu PK; Sav MA; Can Ö; Danyeli AE; Hızal DB; Pamir MN; Özduman K
    World Neurosurg; 2019 Mar; 123():e520-e535. PubMed ID: 30503291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic Endonasal Craniofacial Surgery for Recurrent Skull Base Meningiomas Involving the Pterygopalatine Fossa, the Infratemporal Fossa, the Orbit, and the Paranasal Sinus.
    Shin M; Shojima M; Kondo K; Hasegawa H; Hanakita S; Ito A; Kin T; Saito N
    World Neurosurg; 2018 Apr; 112():e302-e312. PubMed ID: 29339322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of radical microsurgical resection in multimodal treatment for skull base meningioma.
    Ichinose T; Goto T; Ishibashi K; Takami T; Ohata K
    J Neurosurg; 2010 Nov; 113(5):1072-8. PubMed ID: 20225926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of factors affecting the long-term functional outcome of patients with skull base meningioma.
    Nakao N; Ohkawa T; Miki J; Nishibayahsi H; Ogura M; Uematsu Y; Itakura T
    J Clin Neurosci; 2011 Jul; 18(7):895-8. PubMed ID: 21565513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Skull base meningiomas: a predictive system to know the extent of their surgical resection and patient outcome].
    Morales F; Maillo A; Díaz-Alvarez A; Merino M; Muñoz-Herrera A; Hernández J; Santamarta D
    Neurocirugia (Astur); 2005 Dec; 16(6):477-85. PubMed ID: 16378129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression.
    Korhonen K; Salminen T; Raitanen J; Auvinen A; Isola J; Haapasalo H
    J Neurooncol; 2006 Oct; 80(1):1-7. PubMed ID: 16703453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ki-67 index as a predictive marker of meningioma recurrence following surgical resection.
    Mizrachi M; Hartley B; Saleem S; Hintz E; Ziemba Y; Li J; Goenka A; Schulder M
    J Clin Neurosci; 2024 Jun; 124():15-19. PubMed ID: 38631196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
    Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
    Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.